中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 10
Oct.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(10): 1976-1984

Risk factors for the prognosis of elderly patients with hepatitis B virus-related acute-on-chronic liver failure and construction of a nomogram model for risk prediction

DOI: 10.12449/JCH241009
  • 1.

    Department of Gastroenterology，The Affiliated Hospital of Southwest Medical University，Luzhou，Sichuan 646000，China

  • 2.

    Department of Gastroenterology，The General Hospital of Western Theater Command，Chengdu 610083，China

  • 3.

    Department of Gastroenterology，Pidu District People’s Hospital，Chengdu 611730，China

  • 4.

    College of Medicine，Southwest Jiaotong University，Chengdu 610031，China

Research funding:

The Science Foundations of Health Commission of Sichuan Provincial (20PJ180)

More Information
  • Corresponding author: TANG Shanhong， tangshanhong@swjtu.edu.cn （ORCID： 0000-0001-6652-2942）
  • Received Date: 2024-01-19
  • Accepted Date: 2024-02-18
  • Published Date: 2024-10-25
    Abstract
  •   Objective  To investigate the clinical features of elderly patients with hepatitis B virus-related acute-on-chronic liver failure （HBV-ACLF） and the risk factors affecting the short-term prognosis of patients.  Methods  A retrospective analysis was performed for 417 patients with HBV-ACLF who were admitted to The General Hospital of Western Theater Command from January 2015 to January 2023， and related clinical data were collected， including general status， routine blood test results， biochemical parameters， and conditions of liver cirrhosis and decompensated events （ascites， hepatic encephalopathy， and their severities）. The patients were followed up to observe 90-day survival. According to the age， the patients were divided into elderly group （with 106 patients aged ≥60 years） and non-elderly group （with 311 patients aged<60 years）， and according to the 90-day survival， the elderly group were further divided into survival group with 41 patients and death/transplantation group with 65 patients. The independent-samples t test or the Mann-Whitney U test was used for comparison of quantitative data between two groups， and the chi-square test was used for comparison of qualitative data between two groups. The binary logistic regression analysis was used to determine the independent influencing factors for the risk of death within 90 days in elderly patients with HBV-ACLF， and a nomogram model was constructed for predicting the risk of death. The receiver operating characteristic （ROC） curve was used to investigate the value of the model in predicting the prognosis of HBV-ACLF patients in both the training set and the validation set. Calibration curve and decision curve were plotted for the models constructed in the training set and the validation set， and the model was assessed in terms of the degree of fitness and predicting benefits.  Results  The elderly patients had a significantly higher 90-day mortality rate than the non-elderly patients （P<0.05）， and compared with the non-elderly group， the elderly group had significantly higher incidence rate in female individuals， basic incidence rate of liver cirrhosis， incidence rate and grade of hepatic encephalopathy， incidence rate of ascites， and liver fibrosis markers （aspartate aminotransferase-to-platelet ratio index and fibrosis-4） （all P<0.05）， as well as significantly lower total cholesterol， high-density lipoprotein， albumin， alpha-fetoprotein， and lymphocytes （all P<0.05）. As for the elderly patients with HBV-ACLF， there were significant differences between the survival group and the death/transplantation group in total cholesterol， total bilirubin， international normalized ratio （INR）， alpha-fetoprotein， platelet， creatinine， serum sodium， monocytes， and the incidence rate and grade of hepatic encephalopathy （all P<0.05）. In addition， the multivariate logistic regression analysis showed that INR （odds ratio ［OR］=11.351， 95% confidence interval ［CI］： 1.942‍ ‍—‍ ‍66.362， P<0.05）， monocyte count （OR=23.636， 95%CI： 1.388‍ ‍—‍ ‍402.529， P<0.05）， total bilirubin （OR=1.007， 95%CI： 1.001‍ ‍—‍ ‍1.013， P<0.05）， and platelet count （OR=0.968， 95%CI： 0.945‍ ‍—‍ ‍0.993， P<0.05） were independent influencing factors for the 90-day prognosis of elderly patients with HBV-ACLF， and the nomogram model constructed based on these factors had a relatively high predictive value， with an area under the ROC curve of 0.915， a sensitivity of 88.0%， and a specificity of 86.7%. The nomogram model showed relatively high efficiency and degree of fitness in the verification set， and the decision curve suggested that the model had good benefits， with a higher prediction efficiency compared with the commonly used prediction models such as MELD score and COSSH-ACLF Ⅱ score.  Conclusion  Elderly HBV-ACLF patients may have a high short-term mortality rate due to the reductions in liver synthesis， reserve function， and regenerative ability and immune dysfunction. INR， monocyte count， total bilirubin， and platelet count have a relatively high value in predicting the risk of death in elderly HBV-ACLF patients， and the nomogram model constructed based on these factors has a relatively high prediction efficiency.

     

    • FullText(HTML)
  • loading
    • References(22)
  • [1]
    LI X, ZHANG L, PU CM, et al. Liver transplantation in acute-on-chronic liver failure: Timing of transplantation and selection of patient population[J]. Front Med(Lausanne), 2022, 9: 1030336. DOI: 10.3389/fmed.2022.1030336.
    [2]
    Hepatology Branch of Chinese Medical Association, Infectious Diseases Branch of Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B(version 2022)[J]. Chin J Infect Dis, 2023, 41( 1): 3- 28. DOI: 10.3760/cma.j.cn311365-20230220-00050.

    中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2022年版)[J]. 中华传染病杂志, 2023, 41( 1): 3- 28. DOI: 10.3760/cma.j.cn311365-20230220-00050.
    [3]
    LIU L, HAN T, CAI JJ, et al. Clinical characteristics and progression risk factors for hepatitis B-related acute-on-chronic liver failure in elderly patients[J]. Chin J Geriatr, 2022, 41( 1): 51- 56. DOI: 10.3760/cma.j.issn.0254-9026.2022.01.011.

    刘磊, 韩涛, 蔡均均, 等. 老年乙肝相关慢加急性肝衰竭患者临床特点及进展危险因素分析[J]. 中华老年医学杂志, 2022, 41( 1): 51- 56. DOI: 10.3760/cma.j.issn.0254-9026.2022.01.011.
    [4]
    WANG X, ZHAO M, ZHANG C, et al. Establishment and clinical application of the nomogram related to risk or prognosis of hepatocellular carcinoma: A review[J]. J Hepatocell Carcinoma, 2023, 10: 1389- 1398. DOI: 10.2147/jhc.s417123.
    [5]
    ZHANG LJ, TANG L, CHEN SY, et al. A nomogram for predicting the 4-year risk of chronic kidney disease among Chinese elderly adults[J]. Int Urol Nephrol, 2023, 55( 6): 1609- 1617. DOI: 10.1007/s11255-023-03470-y.
    [6]
    CAI ZM, LIN HM, LI ZX, et al. A prediction nomogram for postoperative gastroparesis syndrome in right colon cancer: A retrospective study[J]. Langenbecks Arch Surg, 2023, 408( 1): 148. DOI: 10.1007/s00423-023-02885-6.
    [7]
    Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.

    中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35( 1): 38- 44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
    [8]
    ZHAO RH, SHI Y, ZHAO H, et al. Acute-on-chronic liver failure in chronic hepatitis B: An update[J]. Expert Rev Gastroenterol Hepatol, 2018, 12( 4): 341- 350. DOI: 10.1080/17474124.2018.1426459.
    [9]
    KAKISAKA K, KATAOKA K, ONODERA M, et al. Alpha-fetoprotein: A biomarker for the recruitment of progenitor cells in the liver in patients with acute liver injury or failure[J]. Hepatol Res, 2015, 45( 10): E12- E20. DOI: 10.1111/hepr.12448.
    [10]
    WANG XP, SHEN CF, YANG JJ, et al. Alpha-fetoprotein as a predictive marker for patients with hepatitis B-related acute-on-chronic liver failure[J]. Can J Gastroenterol Hepatol, 2018, 2018: 1232785. DOI: 10.1155/2018/1232785.
    [11]
    QIN S, TANG SH, WANG XH, et al. Value of serum alpha-fetoprotein for the prognostic evaluation of hepatitis B virus-related acute-on-chronic liver failure treated with artificial liver[J]. Chin J Hepatol, 2020, 28( 1): 69- 72. DOI: 10.3760/cma.j.issn.1007-3418.2020.01.016.

    秦森, 汤善宏, 王显红, 等. 血清甲胎蛋白在人工肝治疗乙型肝炎相关慢加急性肝衰竭预后评估中的价值[J]. 中华肝脏病杂志, 2020, 28( 1): 69- 72. DOI: 10.3760/cma.j.issn.1007-3418.2020.01.016.
    [12]
    HOARE M, DAS T, Ageing ALEXANDER G., telomeres, senescence, and injury liver[J]. J Hepatol, 2010, 53( 5): 950- 961. DOI: 10.1016/j.jhep.2010.06.009.
    [13]
    TANG CL, CHEN H, JIANG L, et al. Liver regeneration: Changes in oxidative stress, immune system, cytokines, and epigenetic modifications associated with aging[J]. Oxid Med Cell Longev, 2022, 2022: 9018811. DOI: 10.1155/2022/9018811.
    [14]
    ALLAIRE M, GILGENKRANTZ H. The aged liver: Beyond cellular senescence[J]. Clin Res Hepatol Gastroenterol, 2020, 44( 1): 6- 11. DOI: 10.1016/j.clinre.2019.07.011.
    [15]
    KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33( 2): 464- 470. DOI: 10.1053/jhep.2001.22172.
    [16]
    LI JQ, LIANG X, YOU SL, et al. Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure[J]. J Hepatol, 2021, 75( 5): 1104- 1115. DOI: 10.1016/j.jhep.2021.05.026.
    [17]
    MITCHELL O, FELDMAN DM, DIAKOW M, et al. The pathophysiology of thrombocytopenia in chronic liver disease[J]. Hepat Med, 2016, 8: 39- 50. DOI: 10.2147/HMER.S74612.
    [18]
    XU XW, HOU ZH, XU YY, et al. The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients[J]. Clin Res Hepatol Gastroenterol, 2021, 45( 2): 101482. DOI: 10.1016/j.clinre.2020.06.008.
    [19]
    TU Y, LI X, CHEN MJ, et al. Value of platelet count and related scoring models in predicting the prognosis of hepatitis B virus-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2023, 39( 6): 1308- 1312. DOI: 10.3969/j.issn.1001-5256.2023.06.009.

    涂颖, 李雪, 陈美娟, 等. 血小板计数及相关评分模型对HBV相关慢加急性肝衰竭预后的预测价值[J]. 临床肝胆病杂志, 2023, 39( 6): 1308- 1312. DOI: 10.3969/j.issn.1001-5256.2023.06.009.
    [20]
    ZACCHERINI G, WEISS E, MOREAU R. Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment[J]. JHEP Rep, 2021, 3( 1): 100176. DOI: 10.1016/j.jhepr.2020.100176.
    [21]
    JALAN R, SALIBA F, PAVESI M, et al. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure[J]. J Hepatol, 2014, 61( 5): 1038- 1047. DOI: 10.1016/j.jhep.2014.06.012.
    [22]
    TRIANTAFYLLOU E, WOOLLARD KJ, MCPHAIL MJW, et al. The role of monocytes and macrophages in acute and acute-on-chronic liver failure[J]. Front Immunol, 2018, 9: 2948. DOI: 10.3389/fimmu.2018.02948.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(6)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (365) PDF downloads(50) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return